Mizuho Boosts Welltower (NYSE:WELL) Price Target to $141.00

Welltower (NYSE:WELL) had its price objective lifted by equities research analysts at Mizuho from $136.00 to $141.00 in a research note issued to investors on Thursday,Benzinga reports. The firm presently has an “outperform” rating on the real estate investment trust’s stock. Mizuho’s price target indicates a potential upside of 7.37% from the company’s current price.

A number of other analysts have also issued reports on WELL. Scotiabank increased their target price on Welltower from $133.00 to $142.00 and gave the company a “sector outperform” rating in a report on Monday, November 25th. Deutsche Bank Aktiengesellschaft increased their price objective on Welltower from $115.00 to $137.00 and gave the stock a “buy” rating in a research note on Wednesday, August 21st. Wells Fargo & Company reaffirmed an “equal weight” rating and set a $135.00 target price (up previously from $134.00) on shares of Welltower in a research note on Tuesday, October 1st. Royal Bank of Canada upped their target price on Welltower from $101.00 to $114.00 and gave the company a “sector perform” rating in a report on Friday, August 9th. Finally, Evercore ISI raised their price target on shares of Welltower from $106.00 to $114.00 and gave the stock an “in-line” rating in a report on Monday, September 16th. Five research analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Welltower currently has a consensus rating of “Moderate Buy” and a consensus price target of $120.77.

Welltower Stock Performance

WELL opened at $131.32 on Thursday. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. The firm has a market cap of $81.77 billion, a PE ratio of 86.43, a P/E/G ratio of 2.98 and a beta of 1.20. The business has a fifty day simple moving average of $132.66 and a 200-day simple moving average of $119.13. Welltower has a fifty-two week low of $85.40 and a fifty-two week high of $140.75.

Welltower (NYSE:WELL) last released its quarterly earnings results on Monday, October 28th. The real estate investment trust reported $0.73 earnings per share for the quarter, missing analysts’ consensus estimates of $1.04 by ($0.31). The company had revenue of $2.06 billion during the quarter, compared to analyst estimates of $1.95 billion. Welltower had a net margin of 12.22% and a return on equity of 3.20%. The company’s revenue for the quarter was up 23.7% compared to the same quarter last year. During the same quarter last year, the business earned $0.92 EPS. As a group, equities analysts predict that Welltower will post 4.3 EPS for the current fiscal year.

Hedge Funds Weigh In On Welltower

Several hedge funds have recently bought and sold shares of the business. First Foundation Advisors bought a new position in shares of Welltower in the second quarter valued at approximately $26,000. TruNorth Capital Management LLC bought a new position in Welltower in the 2nd quarter worth $27,000. Meeder Asset Management Inc. acquired a new position in Welltower during the 2nd quarter worth $30,000. Centerpoint Advisors LLC bought a new stake in Welltower during the second quarter valued at about $31,000. Finally, Fortitude Family Office LLC boosted its holdings in Welltower by 37.0% during the third quarter. Fortitude Family Office LLC now owns 289 shares of the real estate investment trust’s stock valued at $37,000 after acquiring an additional 78 shares during the period. 94.80% of the stock is owned by institutional investors and hedge funds.

About Welltower

Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.